|
AU2004233486A1
|
|
Use of apoptosis inducing agents in the treatment of (auto)immune diseases
|
|
WO03089936A1
|
|
Aberrant-specific pathways
|
|
AU2003214721A1
|
|
Fragments of apoptin
|
|
WO02079222A2
|
|
Fusion proteins for specific treatment of cancer and auto-immune diseases
|
|
WO0220809A1
|
|
A delivery method for the tumor specific apoptosis inducing activity of apoptin
|
|
EP1186665A1
|
|
A delivery method for the tumor specific apoptosis inducing activity of apoptin
|
|
EP1264879A1
|
|
Isolation of a cluster of cells from an isolated organ using magnetic particle
|
|
EP1138768A2
|
|
Apoptin-associating protein AAP-5
|
|
IL150774D0
|
|
Apoptin-associating protein
|
|
EP1118662A2
|
|
Apoptin-associating protein
|
|
EP1111045A2
|
|
Apoptin-associating protein
|
|
AU3241301A
|
|
Apoptin-associating protein
|
|
EP1199363A1
|
|
Phosphorylation modifications of apoptin
|
|
EP1188832A1
|
|
A delivery method for the tumor specific apoptosis inducing activity of apoptin
|
|
IL148469D0
|
|
Apoptin-associating protein
|
|
EP1138765A1
|
|
Apoptin-associating proteins AAP-5 and AAP-6
|
|
EP1120463A1
|
|
Apoptin-associating protein
|
|
EP1143994A2
|
|
Use of apoptosis inducing agents in the preparation of a medicament for the treatment of (auto)immune diseases
|
|
JP2001178464A
|
|
Method and means for inducing apoptosis by interference in rna processing
|
|
EP1106691A1
|
|
Apoptin-associating protein
|
